State Street SPDR S&P Pharmaceuticals ETF

XPH · ETF

$62.70−$1.58 (−2.46%)TodayMarket closed · Oct 23, 8:00 PM ET

Prev close $64.28

Latest news

NewsJul 24, 6:25 AM ETStjepan Kalinic
Two Years to Build or Pay 200% — Which US Pharma Stocks Win?
NewsApr 27, 5:57 AM ETAkanksha Bakshi
Why Is Organon Stock Skyrocketing Monday?
NewsApr 22, 7:15 AM ETNabaparna Bhattacharya
Why Is Amneal Pharmaceuticals Stock Gaining Today?
NewsApr 1, 1:36 PM ETVandana Singh
Axsome Stock Climbs On Schizophrenia Drug Deal With Takeda
NewsMar 20, 7:56 AM ETNabaparna Bhattacharya
Prestige Bets $1 Billion On World's Most Iconic Nasal Strip
NewsJan 16, 2:30 AM ETRishabh Mishra
Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks'
NewsDec 19, 3:17 PM ETChandrima Sanyal
Why Health Care ETFs Aren't Panicking Over Big Pharma's Price Cuts
NewsNov 12, 6:22 AM ETRishabh Mishra
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'
NewsSep 29, 3:20 AM ETRishabh Mishra
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms
NewsJul 16, 3:22 AM ETRishabh Mishra
Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains'
NewsJul 11, 7:57 AM ETRishabh Mishra
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies
NewsMay 19, 3:50 AM ETRishabh Mishra
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion
NewsMay 8, 12:08 PM ETChandrima Sanyal
Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks
NewsApr 18, 1:21 PM ETChandrima Sanyal
ETF Shake-Up: UNH's Meltdown Meets LLY's Moonshot
NewsApr 3, 8:25 AM ETSurbhi Jain
Biopharma: A 'Safe Haven' As Tariff Turmoil Rages On?
NewsFeb 28, 11:50 AM ETLekha Gupta
Perrigo Outlines 2025 Growth Plans, Projects Sales Boost And Margin Expansion By 2027
NewsFeb 17, 11:30 AM ETSurbhi Jain
Ken Griffin's Citadel Places Big Short Bet Against GSK - Here's What It Means for Investors

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Two Years to Build or Pay 200% — Which US Pharma Stocks Win?

Why Is Organon Stock Skyrocketing Monday?

Why Is Amneal Pharmaceuticals Stock Gaining Today?

Axsome Stock Climbs On Schizophrenia Drug Deal With Takeda

Prestige Bets $1 Billion On World's Most Iconic Nasal Strip

Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks'

Why Health Care ETFs Aren't Panicking Over Big Pharma's Price Cuts

Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'

Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms

Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains'

Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies

Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion

Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks

ETF Shake-Up: UNH's Meltdown Meets LLY's Moonshot

Biopharma: A 'Safe Haven' As Tariff Turmoil Rages On?

Perrigo Outlines 2025 Growth Plans, Projects Sales Boost And Margin Expansion By 2027

Ken Griffin's Citadel Places Big Short Bet Against GSK - Here's What It Means for Investors